ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission
ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.
Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission tomography system and three Forte gamma cameras, at the end of May. ADAC will begin delivering systems sometime in the company's fiscal year 2001, which begins in October.
The cameras will be installed in the hospital's S. Mark Taper Imaging Department. Nonprofit Cedars-Sinai's imaging department performs more than 264,000 examinations annually.
ADAC claims the gantry-free Skylight system is revolutionary in design. Its architecture allows gamma detectors to be mounted in a room structure, which removes limitations associated with the floor-based mechanical gantries of other nuclear medicine systems. ADAC received FDA approval to market the Skylight in May (SCAN 5/10/00).
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.